Consolidation treatment with yttrium-90 ibritumomab tiuxetan after new induction regimen in advanced stage follicular lymphoma: update results from the Spanish Lymphoma Oncology Group trial after a median follow-up of 8.5-years

Colaboración

Año: 2019

Provencio, M; Franco, F; Gomez-Codina, J; Blanco, CQ; Llanos, M; Garcia-Arroyo, F; de la Cruz, L; Guma, J; Delgado, JR; Alvarez, R; Chacon, JI; Royuela, A; Rueda, A

Título: LEUKEMIA & LYMPHOMA

• Q3